AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 117 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2024. The put-call ratio across all filers is 0.16 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,074,578 | +609.1% | 596,143 | +1200.0% | 0.00% | – |
| Q1 2024 | $292,561 | -13.3% | 45,856 | -12.5% | 0.00% | – |
| Q4 2023 | $337,372 | +176.4% | 52,387 | 0.0% | 0.00% | – |
| Q3 2023 | $122,062 | -2.1% | 52,387 | 0.0% | 0.00% | – |
| Q2 2023 | $124,681 | -31.5% | 52,387 | -48.3% | 0.00% | – |
| Q1 2023 | $181,982 | -10.6% | 101,247 | -5.5% | 0.00% | – |
| Q4 2022 | $203,516 | +78.5% | 107,114 | +100.9% | 0.00% | – |
| Q3 2022 | $114,000 | -25.5% | 53,317 | -1.1% | 0.00% | – |
| Q2 2022 | $153,000 | -49.0% | 53,927 | -25.0% | 0.00% | – |
| Q1 2022 | $300,000 | -62.1% | 71,900 | -52.8% | 0.00% | – |
| Q4 2021 | $791,000 | +143.4% | 152,372 | +207.4% | 0.00% | – |
| Q3 2021 | $325,000 | +122.6% | 49,566 | +125.1% | 0.00% | – |
| Q2 2021 | $146,000 | +13.2% | 22,019 | -2.3% | 0.00% | – |
| Q1 2021 | $129,000 | -35.8% | 22,534 | 0.0% | 0.00% | – |
| Q4 2020 | $201,000 | -28.7% | 22,534 | -7.1% | 0.00% | – |
| Q3 2020 | $282,000 | +55.8% | 24,267 | +115.4% | 0.00% | – |
| Q2 2020 | $181,000 | +154.9% | 11,268 | -4.9% | 0.00% | – |
| Q1 2020 | $71,000 | -57.7% | 11,844 | -6.8% | 0.00% | – |
| Q4 2019 | $168,000 | +5.0% | 12,708 | -1.5% | 0.00% | – |
| Q3 2019 | $160,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $74,286,965 | 86.51% |
| TFG Asset Management GP Ltd | 8,000,000 | $27,840,000 | 6.94% |
| STEMPOINT CAPITAL LP | 2,662,732 | $9,266,307 | 2.72% |
| Exome Asset Management LLC | 839,472 | $2,921,362 | 2.54% |
| GREAT POINT PARTNERS LLC | 3,441,667 | $11,977,001 | 2.29% |
| Affinity Asset Advisors, LLC | 4,300,000 | $14,964,000 | 1.72% |
| Deep Track Capital, LP | 15,272,172 | $53,147,159 | 1.59% |
| Frazier Life Sciences Management, L.P. | 4,623,324 | $16,089,168 | 0.75% |
| HighVista Strategies LLC | 518,820 | $1,805,494 | 0.66% |
| Avoro Capital Advisors LLC | 12,345,678 | $42,962,959 | 0.57% |